133 related articles for article (PubMed ID: 23790618)
1. [Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?].
Martínez-Martínez A; Martínez-Bosch J
Radiologia; 2014; 56(1):35-43. PubMed ID: 23790618
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
[TBL] [Abstract][Full Text] [Related]
3. The role of diffusion and perfusion magnetic resonance imaging in differentiation of haemangioblastomas and pilocytic astrocytomas.
Neska-Matuszewska M; Zimny A; Bladowska J; Czarnecka A; Sąsiadek M
Pol J Radiol; 2018; 83():e197-e203. PubMed ID: 30627235
[TBL] [Abstract][Full Text] [Related]
4. Perfusion-sensitive MRI of pilocytic astrocytomas: initial results.
Grand SD; Kremer S; Tropres IM; Hoffmann DM; Chabardes SJ; Lefournier V; Berger FR; Pasteris C; Krainik A; Pasquier BM; Peoch M; Le Bas JF
Neuroradiology; 2007 Jul; 49(7):545-50. PubMed ID: 17530237
[TBL] [Abstract][Full Text] [Related]
5. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.
Smitha KA; Gupta AK; Jayasree RS
Br J Radiol; 2015 Aug; 88(1052):20140784. PubMed ID: 26110202
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.
She DJ; Xing Z; Zeng Z; Shang XY; Cao DR
Neuroradiology; 2015 Mar; 57(3):275-81. PubMed ID: 25487356
[TBL] [Abstract][Full Text] [Related]
7. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
8. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
9. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of perfusion weighted magnetic resonance imaging with signal-intensity curves analysis in the differential diagnosis of sellar and parasellar tumors: preliminary report.
Bladowska J; Zimny A; Guziński M; Hałoń A; Tabakow P; Czyż M; Czapiga B; Jarmundowicz W; Sąsiadek MJ
Eur J Radiol; 2013 Aug; 82(8):1292-8. PubMed ID: 23466030
[TBL] [Abstract][Full Text] [Related]
11. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
12. [The heterogeneity of blood flow on magnetic resonance imaging: a biomarker for grading cerebral astrocytomas].
Revert Ventura AJ; Sanz Requena R; Martí-Bonmatí L; Pallardó Y; Jornet J; Gaspar C
Radiologia; 2014; 56(4):328-38. PubMed ID: 22738943
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging.
Preul C; Kühn B; Lang EW; Mehdorn HM; Heller M; Link J
Eur J Radiol; 2003 Dec; 48(3):244-51. PubMed ID: 14652141
[TBL] [Abstract][Full Text] [Related]
14. Perfusion MR imaging in gliomas: comparison with histologic tumor grade.
Lee SJ; Kim JH; Kim YM; Lee GK; Lee EJ; Park IS; Jung JM; Kang KH; Shin T
Korean J Radiol; 2001; 2(1):1-7. PubMed ID: 11752962
[TBL] [Abstract][Full Text] [Related]
15. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
[TBL] [Abstract][Full Text] [Related]
16. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?
Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z
AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427
[TBL] [Abstract][Full Text] [Related]
17. Diffusion and perfusion MR patterns of central nervous system lymphomas.
Neska-Matuszewska M; Zimny A; Bladowska J; Sąsiadek M
Adv Clin Exp Med; 2018 Aug; 27(8):1099-1108. PubMed ID: 29975467
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the mismatched manifestation between rCBF and rCBV maps in cerebral astrocytomas.
Hu CH; Fang XM; Hu XY; Cui L
Clin Imaging; 2009; 33(6):417-23. PubMed ID: 19857800
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
[TBL] [Abstract][Full Text] [Related]
20. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
